¼¼°èÀÇ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå º¸°í¼­(2025³â)
Chondroitin Sulfate Global Market Report 2025
»óǰÄÚµå : 1775926
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,283,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,082,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,880,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ½Äǰ°ú À½½Ä¿¡ÀÇ ÅëÇÕ, Àü·«Àû ¸¶ÄÉÆÃ, °Ç°­ Ä·ÆäÀÎ µî¿¡ ±âÀÎÇÑ´Ù°í »ý°¢µË´Ï´Ù. ¿¹Ãø ±â°£¿¡ À־ÀÇ ¼¼°èÀÇ µ¿Çâ¿¡´Â Áö¼Ó °¡´ÉÇÑ Á¶´Þ¿¡ ´ëÇÑ ÁÖ¸ñ, ÃßÃ⡤»ý»ê ±â¼úÀÇ Áøº¸, ¹Ý·Áµ¿¹°¿ë ¿µ¾ç º¸Á¶ ½ÄǰÀÇ ¼ºÀå, °üÀýÀÇ °Ç°­ È¿°ú¿¡ ´ëÇÑ ÀνÄ, ¼¼°è ½ÃÀåÀÇ È®´ë µîÀÌ Æ÷ÇԵ˴ϴÙ.

ÇâÈÄ 5³â°£ 5.5%ÀÇ ¼ºÀå·ü Àü¸ÁÀº ÀÌ ½ÃÀå¿¡ ´ëÇÑ ÀÌÀü ÃßÁ¤Ä¡¿¡¼­ 0.4% ¼ÒÆø °¨¼ÒÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ÀÌ °¨¼Ò´Â ÁÖ·Î ¹Ì±¹°ú Ÿ±¹°£ÀÇ °ü¼¼ÀÇ ¿µÇâ¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù. ¿µ¾ç º¸Á¶ ½ÄǰÀ̳ª ÀǾàǰÀÇ ºñ¿ëÀÌ »ó½ÂÇØ, ¹Ì±¹¿¡ Á÷Á¢ ¿µÇâÀ» ¹ÌÄ¥ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¶Ç, »óÈ£ °ü¼¼³ª, ¹«¿ª ¸¶ÂûÀ̳ª ¹«¿ª Á¦ÇÑÀÇ °ÝÈ­¿¡ ÀÇÇÑ ¼¼°è °æÁ¦³ª ¹«¿ª¿¡ÀÇ ¾Ç¿µÇâ¿¡ ÀÇÇØ ¿µÇâÀº º¸´Ù ³Ð°Ô ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°ñ°üÀý¿°ÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ Äܵå·ÎÀÌÆ¾ Ȳ»ê ½ÃÀå ¼ºÀåÀ» À̲ø °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Äܵå·ÎÀÌÆ¾ Ȳ»êÀº ¾ÐÃà¿¡ ´ëÇÑ ÀúÇ×·ÂÀ» ºÎ¿©ÇÏ°í ±¸Á¶Àû ¹«°á¼ºÀ» À¯ÁöÇÏ°í µ¿Á¾ ¿ä¹ýÀ» ÃËÁøÇϰí ÅðÇà °úÁ¤À» Áö¿¬½ÃŰ°í ±ÙÀ°ÅëÀ» ¿ÏÈ­ÇÔÀ¸·Î½á °ñ°üÀý¿°ÀÇ ÅëÁõ °ü¸®¿¡ À¯ÀÍÇÕ´Ï´Ù. Äܵå·ÎÀÌÆ¾ Ȳ»ê¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÏ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ °ñ´Ù°øÁõ¿¡ ÀÇÇÑ ¿¬°£ °ñÀý °Ç¼ö´Â 2040³â±îÁö 68% Áõ°¡ÇÏ¿© 320¸¸ °Ç¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Chondroitin sulfate is a chemical compound naturally present in human and animal cartilage, commonly utilized in the treatment of osteoarthritis, often in combination with other substances such as glucosamine. This condition involves the deterioration of joint cartilage, a process that chondroitin sulfate aims to mitigate, given its essential role in cartilage structure.

The primary forms of chondroitin sulfate include capsules, tablets, and powder formulations. Capsules are measured-out containers containing medication that dissolves upon ingestion. Chondroitin sulfate is sourced from various origins, including bovine, swine, poultry, shark, and synthetic sources. It finds applications in pet food and veterinary supplements, pharmaceutical and biotech industries, cosmetics, and personal care products.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The escalating U.S. tariffs and rising trade tensions in spring 2025 are expected to significantly affect the chemicals sector, which is facing a disproportionate impact-particularly from tariffs on petrochemicals and intermediates, where affordable domestic alternatives are limited. Specialty chemical producers, who rely heavily on Chinese raw materials, are encountering production disruptions. Meanwhile, fertilizer manufacturers are seeing their profit margins squeezed due to tariffs on phosphate imports. In response, companies are increasing investments in R&D for bio-based alternatives, forming procurement alliances to strengthen purchasing power, and relocating production to tariff-neutral countries like Saudi Arabia.

The chondroitin sulfate market research report is one of a series of new reports from The Business Research Company that provides chondroitin sulfate market statistics, including chondroitin sulfate industry global market size, regional shares, competitors with a chondroitin sulfate market share, detailed chondroitin sulfate market segments, market trends and opportunities, and any further data you may need to thrive in the chondroitin sulfate industry. This chondroitin sulfate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chondroitin sulfate market size has grown steadily in recent years. It will grow from $1.43 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 3.2%. The growth in the historic period can be attributed to growing aging population and joint health awareness, prevalence of osteoarthritis and joint disorders, expansion of dietary supplement industry, consumer interest in natural and nutraceutical products, rise in sports and fitness activities.

The chondroitin sulfate market size is expected to see strong growth in the next few years. It will grow to $1.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to expanding applications in veterinary medicine, research advances and clinical validation, global rise in lifestyle-related joint issues, incorporation in functional foods and beverages, strategic marketing, and health campaigns. Major trends in the forecast period include focus on sustainable sourcing, advancements in extraction and production technologies, growth in pet nutraceuticals, awareness of joint health benefits, global market expansion.

The forecast of 5.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by raising nutraceutical and pharmaceutical costs, as bovine and shark cartilage extracts from Brazil and Spain face supply issues.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of osteoarthritis is anticipated to drive the growth of the chondroitin sulfate market in the future. Osteoarthritis is a common form of arthritis that impacts millions worldwide. It develops when the protective cartilage cushioning the ends of bones progressively wears away. Chondroitin sulfate is beneficial in managing osteoarthritis by providing resistance to compression, preserving structural integrity, promoting homeostasis, slowing the degenerative process, and alleviating muscle pain. As a result, the rising incidence of osteoarthritis will boost the demand for chondroitin sulfate. For example, in May 2022, Amgen, a biotechnology company based in the US, reported that osteoporosis leads to approximately 1.5 million fractures annually in the United States, incurring $19 billion in related costs. Furthermore, the annual number of fractures due to osteoporosis is expected to rise by 68% by 2040, reaching 3.2 million. Therefore, the growing occurrence of osteoarthritis is fueling the expansion of the chondroitin sulfate market.

The chondroitin sulfate market is set to benefit from the increasing demand in the pharmaceutical industry. The pharmaceutical industry, dedicated to research, development, production, and marketing of drugs and medications for medical treatment, utilizes chondroitin sulfate in joint health supplements. These supplements provide relief from pain and swelling associated with various joint disorders and are employed in transdermal drug delivery systems. In June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that the total pharmaceutical production in Europe reached $384,200 million (€340,000 million) in 2022, marking a 4.95% increase from the previous year. This upward trend in pharmaceutical demand is a significant driver for the growth of the chondroitin sulfate market.

The growing demand for nutraceutical products is projected to drive the expansion of the chondroitin sulfate market in the future. Nutraceuticals are defined as substances that provide physiological benefits or protect against chronic diseases. These products aim to enhance overall health, prevent chronic conditions, promote longevity, or support the body's structure and function. Chondroitin sulfate is commonly utilized in nutraceuticals as a dietary ingredient to relieve symptoms associated with osteoarthritis; therefore, the increasing demand for nutraceuticals boosts the demand for chondroitin sulfate. For example, in March 2024, the Ministry of Food Processing Industries, a government body in India, reported that the Indian nutraceutical market is expected to reach USD 11 billion by 2023, with a CAGR of 21%. Thus, the rising demand for nutraceutical products is fueling the growth of the chondroitin sulfate market.

Product innovation stands out as a prominent trend gaining traction in the chondroitin sulfate market. Major companies within the market are actively introducing new products to fortify their positions and meet evolving consumer needs. A noteworthy example is the launch by Infinitus, a China-based herbal health products and services company, in July 2022. Infinitus introduced a new series of Li Mai Jian supplements with a theme centered around 'Making Bones Stronger for Joint Health.' Scientifically formulated with coix seeds and lobed kudzu vine root, these supplements provide additional care for joints, reflecting the industry's commitment to advancing product offerings.

Major companies in the chondroitin sulfate market are increasingly focusing on strategic partnerships to enhance their profitability. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in March 2022, Bioiberica Nebraska Inc., a US-based life science company that supplies chondroitin sulfate, formed a partnership with ByHealth. Through this collaboration, Bioiberica Nebraska Inc. aims to develop a new product for its joint health brand, Highflex, tailored for the Chinese market, while also educating Chinese consumers about the benefits of collagen supplementation for joint health. ByHealth is a China-based provider of vitamins and dietary supplements (VDS).

Major companies operating in the chondroitin sulfate market include Seikagaku Corporation, Synutra Ingredients, TSI Group Ltd., Sioux Pharm, Summit Nutritionals International Inc., ZPD A/S, Sino Siam Bio technique Co. Ltd., Bio-gen Extracts Pvt. Ltd., Hebei Sanxin industry Group Co.Ltd., Sigma Aldrich Inc., Fidia Farmaceutici S.p.A., Gnosis S.p.A., Pacific Rainbow International Inc., Bioiberica S.A.U., Merck KGaA, Ruikangda Biochemical Co. Ltd., Guanglong Biochem Co. Ltd., Nippon Zoki Pharmaceutical Co. Ltd., Huiwen Technology Co. Ltd., Runxin Biotechnology Co. Ltd., Yangtze River Basin Construction Co. Ltd., Focus Technology Co. Ltd., WanTuMing Biological, QJBCHINA, Hengjie Bio-Pharmaceuticals, Rochem International Inc., Chongqing Aoli Biopharmaceutical Co. Ltd.

North America was the largest region in the chondroitin sulfate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chondroitin sulfate market report during the forecast period. The regions covered in the chondroitin sulfate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chondroitin sulfate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chondroitin sulfate market consists of sales of glucuronic acid and N-acetylga-lactosamine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chondroitin Sulfate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chondroitin sulfate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chondroitin sulfate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chondroitin sulfate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Chondroitin Sulfate Market Characteristics

3. Chondroitin Sulfate Market Trends And Strategies

4. Chondroitin Sulfate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Chondroitin Sulfate Growth Analysis And Strategic Analysis Framework

6. Chondroitin Sulfate Market Segmentation

7. Chondroitin Sulfate Market Regional And Country Analysis

8. Asia-Pacific Chondroitin Sulfate Market

9. China Chondroitin Sulfate Market

10. India Chondroitin Sulfate Market

11. Japan Chondroitin Sulfate Market

12. Australia Chondroitin Sulfate Market

13. Indonesia Chondroitin Sulfate Market

14. South Korea Chondroitin Sulfate Market

15. Western Europe Chondroitin Sulfate Market

16. UK Chondroitin Sulfate Market

17. Germany Chondroitin Sulfate Market

18. France Chondroitin Sulfate Market

19. Italy Chondroitin Sulfate Market

20. Spain Chondroitin Sulfate Market

21. Eastern Europe Chondroitin Sulfate Market

22. Russia Chondroitin Sulfate Market

23. North America Chondroitin Sulfate Market

24. USA Chondroitin Sulfate Market

25. Canada Chondroitin Sulfate Market

26. South America Chondroitin Sulfate Market

27. Brazil Chondroitin Sulfate Market

28. Middle East Chondroitin Sulfate Market

29. Africa Chondroitin Sulfate Market

30. Chondroitin Sulfate Market Competitive Landscape And Company Profiles

31. Chondroitin Sulfate Market Other Major And Innovative Companies

32. Global Chondroitin Sulfate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chondroitin Sulfate Market

34. Recent Developments In The Chondroitin Sulfate Market

35. Chondroitin Sulfate Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â